BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15313919)

  • 21. Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients.
    Tan Y; Zavala J; Xu M; Zavala J; Hoffman RM
    Anticancer Res; 1996; 16(6C):3937-42. PubMed ID: 9042316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.
    Kawaguchi K; Han Q; Li S; Tan Y; Igarashi K; Kiyuna T; Miyake K; Miyake M; Chmielowski B; Nelson SD; Russell TA; Dry SM; Li Y; Singh AS; Eckardt MA; Unno M; Eilber FC; Hoffman RM
    Cell Cycle; 2018; 17(3):356-361. PubMed ID: 29187018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics, methionine depletion, and antigenicity of recombinant methioninase in primates.
    Yang Z; Wang J; Yoshioka T; Li B; Lu Q; Li S; Sun X; Tan Y; Yagi S; Frenkel EP; Hoffman RM
    Clin Cancer Res; 2004 Mar; 10(6):2131-8. PubMed ID: 15041734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Afterword: Oral Methioninase-Answer to Cancer and Fountain of Youth?
    Hoffman RM; Han Q; Kawaguchi K; Li S; Tan Y
    Methods Mol Biol; 2019; 1866():311-322. PubMed ID: 30725426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot Phase I Clinical Trial of Methioninase on High-Stage Cancer Patients: Rapid Depletion of Circulating Methionine.
    Hoffman RM; Tan Y; Li S; Han Q; Zavala J; Zavala J
    Methods Mol Biol; 2019; 1866():231-242. PubMed ID: 30725419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration.
    Gao JQ; Eto Y; Yoshioka Y; Sekiguchi F; Kurachi S; Morishige T; Yao X; Watanabe H; Asavatanabodee R; Sakurai F; Mizuguchi H; Okada Y; Mukai Y; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    J Control Release; 2007 Sep; 122(1):102-10. PubMed ID: 17628160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticancer efficacy of methioninase in vivo.
    Tan Y; Xu M; Guo H; Sun X; Kubota T; Hoffman RM
    Anticancer Res; 1996; 16(6C):3931-6. PubMed ID: 9042315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model.
    Baker DP; Lin EY; Lin K; Pellegrini M; Petter RC; Chen LL; Arduini RM; Brickelmaier M; Wen D; Hess DM; Chen L; Grant D; Whitty A; Gill A; Lindner DJ; Pepinsky RB
    Bioconjug Chem; 2006; 17(1):179-88. PubMed ID: 16417267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective Metabolic Targeting of Human Osteosarcoma Cells
    Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Murakami T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Hoffman RM
    Anticancer Res; 2017 Sep; 37(9):4807-4812. PubMed ID: 28870899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
    Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
    J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of divalent polyethylene glycol units, conjugated on human granulocyte colony-stimulating factor, on biological activities in vitro and in vivo.
    Yamasaki M; Asano M; Yokoo Y; Okabe M
    Drugs Exp Clin Res; 1998; 24(4):191-6. PubMed ID: 10051965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated PEGylated polylysine dendrimers.
    Kaminskas LM; Kelly BD; McLeod VM; Sberna G; Boyd BJ; Owen DJ; Porter CJ
    Mol Pharm; 2011 Apr; 8(2):338-49. PubMed ID: 21171585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased tyrosine phenol-lyase activity in mice following pyridoxal phosphate administration.
    Elmer GW; Minor L; Meadows GG; Spackman DH; Riley V
    Cancer Res; 1978 Nov; 38(11 Pt 1):3663-7. PubMed ID: 698926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimers.
    Kaminskas LM; Kelly BD; McLeod VM; Boyd BJ; Krippner GY; Williams ED; Porter CJ
    Mol Pharm; 2009; 6(4):1190-204. PubMed ID: 19453158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics, immunogenicity and anticancer efficiency of Aspergillus flavipes L-methioninase.
    El-Sayed AS; Shouman SA; Nassrat HM
    Enzyme Microb Technol; 2012 Sep; 51(4):200-10. PubMed ID: 22883554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A highly enhanced thrombopoietic activity by monomethoxy polyethylene glycol-modified recombinant human interleukin-6.
    Inoue H; Kadoya T; Kabaya K; Tachibana K; Nishi N; Sato M; Ohsawa M; Mikayama T; Mori KJ
    J Lab Clin Med; 1994 Oct; 124(4):529-36. PubMed ID: 7930877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Efficacy of Recombinant Methioninase on Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Cancer.
    Hoffman RM; Murakami T; Kawaguchi K; Igarashi K; Tan Y; Li S; Han Q
    Methods Mol Biol; 2019; 1866():149-161. PubMed ID: 30725414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
    Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
    Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide.
    Fang J; Sawa T; Akaike T; Maeda H
    Cancer Res; 2002 Jun; 62(11):3138-43. PubMed ID: 12036926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.